1-3 of 3 results for subject:Psilocybin
Librarians' tools
- Search time
- 0.174 seconds
- Solr query time
- 0.004 seconds
- Search query
- subject:Psilocybin
- We searched for
- subject_t:Psilocybin OR subject_ses:472385
Type
House
Session
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health and Social Care, what support he is providing to innovative research into using psilocybin to treat depression.
To ask the Secretary of State for Health and Social Care, what support he is providing to innovative research into using psilocybin to treat depression.
The Department, through the National Institute for Health Research (NIHR) has funded or supported various studies into the use of psilocybin to treat depression. The NIHR’s Research Programmes has invested £1.1 million in the study ‘A Feasibility RCT of Single-Dose Psilocybin in Unipolar Depressive Disorder Resistant to Standard Treatments’.
To ask the Secretary of State for Health and Social Care, with reference to the letter of 16 October 2020 from the Minister with responsibility for drugs to the hon. Member for Reigate, what assessment he has made of the implications for his policies of emerging evidence on the use...
To ask the Secretary of State for Health and Social Care, with reference to the letter of 16 October 2020 from the Minister with responsibility for drugs to the hon. Member for Reigate, what assessment he has made of the implications for his policies of emerging evidence on the use...
The Government has made no recent assessment of the potential merits of rescheduling psilocybin, which remains a Schedule 1 substance under the Misuse of Drugs Regulations 2001 (the 2001 Regulations).
Ministers continue to take a close interest in any new evidence relating to controlled drugs and they would seek expert advice from the Advisory Council on the Misuse of Drugs before making any amendments to the 2001 Regulations.
To ask the Secretary of State for the Home Department, what assessment her Department has made of the potential merits of rescheduling psilocybin.
To ask the Secretary of State for the Home Department, what assessment her Department has made of the potential merits of rescheduling psilocybin.
The Government has made no recent assessment of the potential merits of rescheduling psilocybin, which remains a Schedule 1 substance under the Misuse of Drugs Regulations 2001 (the 2001 Regulations).
Ministers continue to take a close interest in any new evidence relating to controlled drugs and they would seek expert advice from the Advisory Council on the Misuse of Drugs before making any amendments to the 2001 Regulations.